Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Julphar
Fuji
Citi
Dow
Novartis
Moodys
Merck
Baxter
Teva

Generated: January 16, 2018

DrugPatentWatch Database Preview

EPTIFIBATIDE Drug Profile

« Back to Dashboard

US Patents and Regulatory Information for EPTIFIBATIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 205557-001 Nov 6, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 206127-001 Dec 8, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 204589-002 Apr 18, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 206127-002 Dec 8, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 205557-002 Nov 6, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 204589-001 Apr 18, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 205581-002 Dec 8, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 205581-001 Dec 8, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 091555-001 Jun 5, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 090854-001 Jun 12, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Citi
Cipla
Harvard Business School
Chubb
US Department of Justice
UBS
Julphar
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot